Drug interactions
Ertugliflozin-sitagliptin + Fosamprenavir
Severity: Minor
Ertugliflozin-sitagliptin and Fosamprenavir: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Protease inhibitors can cause insulin resistance and hyperglycemia, which may reduce the effectiveness of antidiabetic therapy. The effect varies between patients and can develop over weeks to months.
What this interaction means in plain words
Ertugliflozin-sitagliptin and Fosamprenavir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Protease inhibitor-associated insulin resistance counteracting glucose-lowering drugs.
What to do
Monitor glucose and HbA1c after starting fosamprenavir and adjust antidiabetic therapy if control worsens.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ertugliflozin-sitagliptin and Fosamprenavir, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ertugliflozin-sitagliptin
Frequently asked questions
Can I take Ertugliflozin-sitagliptin with Fosamprenavir?
MediHelp rates the interaction as minor. Ertugliflozin-sitagliptin and Fosamprenavir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Protease inhibitors can cause insulin resistance and hyperglycemia, which may reduce the effectiveness of antidiabetic therapy. The effect varies between patients and can develop over weeks to months.
How serious is the interaction between Ertugliflozin-sitagliptin and Fosamprenavir?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose and HbA1c after starting fosamprenavir and adjust antidiabetic therapy if control worsens.
What other medicines interact with Ertugliflozin-sitagliptin?
MediHelp also lists interactions of Ertugliflozin-sitagliptin with, for example, Albiglutide, Aripiprazole, Asenapine. The full list is on the Ertugliflozin-sitagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
